Wacker Biotech partners with Caeregen Therapeutics on regenerative treatment for vision loss
As Caeregen’s CDMO partner for CTR-107, Wacker Biotech will produce drug substance at its site in Halle, Germany, and complete clinical trial drug product production at its site in Amsterdam, the Netherlands